GlaxoSmithKline (Brazil)

Recent papers from GlaxoSmithKline (Brazil)

1. United States healthcare providers’ views on pediatric meningococcal disease and vaccinationExpert Review of Vaccines · 2026
2. Considerations for Recycling of Acetonitrile in Oligonucleotide SynthesisOrganic Process Research & Development · 2026
3. Restoring well-being: quality of life improvements following dolutegravir-based therapy after antiretroviral failureThe Brazilian Journal of Infectious Diseases · 2026
4. Respiratory Syncytial Virus Hospitalizations Among Adults in Thailand: A Nationwide Retrospective Observational Study (RSV‐HAT)Influenza and Other Respiratory Viruses · 2026
5. From Diagnosis to Execution: A National Plan Proposal to Redesign Clinical Research in Brazil to Improve Cancer Care and Innovation Access.2026
6. Modeling the Public Health Impact of Introducing 4CMenB Vaccination for Infants in the Brazilian National Immunization ProgramInfectious Diseases and Therapy · 2026
7. Exploring Platinum-Based Treatment Realities: What do Real-World Data Reveal for the Management of Endometrial Cancer in Brazil? – the ECHOS-B Retrospective StudyBrazilian Journal of Oncology · 2026
8. On the Intracycle Performance of a S-Shaped Vertical Axis Autorotation Current Turbine (VAACT) by Computational Fluid DynamicsJournal of Offshore Mechanics and Arctic Engineering · 2026
9. Targeting Immunologic Pathways in Eosinophilic Granulomatosis With Polyangiitis: Translating Emerging Evidence Into Clinical PracticeAllergy · 2026
10. Emerging Real-World Treatment Patterns and Clinical Outcomes of Multiple Myeloma in Argentina and Brazil: Insights from the TOTEMM Study in the Private Healthcare SectorCurrent Oncology · 2025
11. Burden of Treatment, Treatment Sequencing and Healthcare Resource Utilization in Multiple Myeloma in Latin America: A Targeted Literature ReviewOncology and Therapy · 2025
12. Burden of Treatment, Treatment Sequencing and Healthcare Resource Utilization in Multiple Myeloma in Latin America: A Targeted Literature ReviewOncology and Therapy · 2025
13. The IFPMA IVS seasonal influenza vaccine dose distribution survey 2022–2023: evidence of the need for committed national investment in and uptake of seasonal influenza vaccinationVaccine · 2025
14. The immunomodulatory and antitumor properties of the bacterial metalloprotease Oligopeptidase A are mediated by TLR4/MyD88/TRIF and MAPK signaling pathwaysFrontiers in Immunology · 2025
15. Public health impact of the adjuvanted RSVPreF3 vaccine in adults aged 60 years and older: results from a modeling study in six Latin American countriesExpert Review of Vaccines · 2025
16. Yellow fever in South America – A plea for action and call for prevention also in travelers from SLAMVI, ESGITM, EVASG, ALEIMC, GEPI-SEIMC, SEMEVI, and CMTZMV-ACINTravel Medicine and Infectious Disease · 2025
17. Definition and application of systemic lupus erythematosus disease modification in emerging markets: Delphi panel consensus recommendationsLupus · 2025
18. An observational pilot study of an active surveillance tool to enhance pharmacovigilance in BrazilMalaria Journal · 2025
19. Real-World Effectiveness of Intravenous Belimumab on Clinical Outcomes in Patients With Systemic Lupus Erythematosus in Saudi Arabia: The OBSErve Observational StudyOpen Access Rheumatology Research and Reviews · 2025
20. Regional challenges to optimize the management of patients with severe asthma type 2 inflammation: a Delphi consensus in seven countriesJournal of Asthma · 2025